Macroplata, Inc.
USPTO PatentsView assignee record - 7 granted patents across 2 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Macroplata ranks #36,337 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 2 technology areas.
- #36,337
- of 49,997 US assignees by volume
- 16th percentile
- by Innovation Score (24.9/100)
- 21.1
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R36337 · US Corporation #36,337 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 7 grants
- MID-PACK #36,337/49,997
- PHOTO-FINISH Maana
- CPC-NARROW A61B · 2 areas
- INNOV-THIN 24.9/100
- CLAIMS-DENSE 21.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Maana, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Macroplata’s 24.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Macroplata
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Macroplata · this assignee 25
Macroplata · this assignee
25 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Macroplata's Innovation Score is 24.9/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Macroplata?
Each dot is one of Macroplata’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Macroplata’s own 21.1 claims/patent is ABOVE the 15.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Macroplata's grants concentrate
Macroplata, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (6 grants) versus a trough of 1 in 2017. By volume, Macroplata sits between Mycelebs Co., Ltd. and Magnetic Autocontrol GmbH.
Who files at Macroplata's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Mycelebs
Mycelebs Co., Ltd.
7 patents
- Mycelx
Mycelx Technologies Corporation
7 patents
- Maana
Maana, Inc.
7 patents
- Maastricht Univer…
Maastricht University
7 patents
- Maddoc Medical Pr…
Maddoc Medical Products, Inc.
7 patents
- Magpump
MagPump, LLC
7 patents
- Maginatics
Maginatics LLC
7 patents
- Magnetic Autocont…
Magnetic Autocontrol GmbH
7 patents
- Macroplata ◀
Macroplata, Inc.
7 patents
What this shows Macroplata holds 7 patents at rank #36,440, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Macroplata
By rank, the assignees closest to #36,440 in granted patent volume.
- Mycelebs Co., Ltd. #36,436 · 7 patents
- Mycelx Technologies Corporation #36,437 · 7 patents
- Maana, Inc. #36,438 · 7 patents
- Maastricht University #36,439 · 7 patents
- Maddoc Medical Products, Inc. #36,441 · 7 patents
- MagPump, LLC #36,442 · 7 patents
- Maginatics LLC #36,443 · 7 patents
- Magnetic Autocontrol GmbH #36,444 · 7 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Macroplata's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Macroplata's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
25 16th percentile higher than 16% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 85.7% |
| 2017 | 1 | 14.3% |
Which technologies does Macroplata, Inc. patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Macroplata, Inc.'s patent record in context - here's where to go next.
- Macroplata, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #36,337 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Macroplata, Inc. against Mycelebs Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 24.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.